Interesting article, which bodes well for AVX. http://money.cnn.com/2007/11/19/news/companies/hiv/index.htm?postversion=2007111913
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress